|
Gene Ontology
|
| GO:0001525 |
angiogenesis |
0,01 |
| GO:0000082 |
G1/S transition of mitotic cell cycle |
0,01 |
| GO:0043067 |
regulation of programmed cell death |
0,02 |
| GO:0051252 |
regulation of RNA metabolic process |
0,02 |
| GO:0042981 |
regulation of apoptosis |
0,02 |
| GO:0006355 |
regulation of transcription. DNA-dependent |
0,02 |
| GO:0009887 |
organ morphogenesis |
0,02 |
| GO:0001944 |
vasculature development |
0,03 |
| GO:0006916 |
anti-apoptosis |
0,03 |
| GO:0048705 |
skeletal system morphogenesis |
0,03 |
| GO:0001568 |
blood vessel development |
0,04 |
| GO:0046395 |
carboxylic acid catabolic process |
0,07 |
| GO:0048514 |
blood vessel morphogenesis |
0,07 |
| GO:0016477 |
cell migration |
0,09 |
|
Pathway
|
| Metacore |
PGE2 pathways in cancer |
0 |
| Metacore |
Immune response_Histamine signaling in dendritic cells |
0,00013 |
| Metacore |
Signal transduction_cAMP signaling |
0,00015 |
| Metacore |
Development_S1P1 receptor signaling via beta-arrestin |
0,00019 |
| Metacore |
Muscle contraction_Regulation of eNOS activity in endothelial cells |
0,00021 |
| Metacore |
Immune response_Histamine H1 receptor signaling in immune response |
0,00022 |
| Metacore |
Cell adhesion_Chemokines and adhesion |
0,00022 |
| Metacore |
Development_Mu-type opioid receptor signaling via Beta-arrestin |
0,00032 |
| Metacore |
Immune response_PGE2 signaling in immune response |
0,00038 |
| Metacore |
Development_S1P2 and S1P3 receptors in cell proliferation and differentiation |
0,00055 |
| KEGG |
ECM-receptor interaction |
0,009 |
